Joel Greenblatt's COLL Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 10,404 shares of Collegium Pharmaceutical, Inc. (COLL) worth $481,705, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in COLL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 18,992 shares. Largest reduction occurred in Q1 2025, reducing 28,074 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,219 | Add 27.11% | 10,404 | $46.30 |
| Q3 2025 | +8,185 | New Buy | 8,185 | $34.99 |
| Q1 2025 | -28,074 | Sold Out | 0 | $0.00 |
| Q4 2024 | -24,032 | Reduce 46.12% | 28,074 | $28.65 |
| Q3 2024 | -9,311 | Reduce 15.16% | 52,106 | $38.64 |
| Q2 2024 | +8,995 | Add 17.16% | 61,417 | $32.20 |
| Q1 2024 | +7,560 | Add 16.85% | 52,422 | $38.82 |
| Q4 2023 | +1,899 | Add 4.42% | 44,862 | $30.78 |
| Q3 2023 | +10,489 | Add 32.30% | 42,963 | $22.35 |
| Q2 2023 | +18,992 | Add 140.87% | 32,474 | $21.49 |
| Q1 2023 | +13,482 | New Buy | 13,482 | $23.99 |
| Q3 2021 | -11,348 | Sold Out | 0 | $0.00 |
| Q2 2021 | +11,348 | New Buy | 11,348 | $23.62 |
Joel Greenblatt's Collegium Pharmaceutical Investment FAQs
Joel Greenblatt first purchased Collegium Pharmaceutical, Inc. (COLL) in Q2 2021, acquiring 11,348 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Collegium Pharmaceutical, Inc. (COLL) for 13 quarters since Q2 2021.
Joel Greenblatt's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q2 2023, adding 32,474 shares worth $697,866.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 10,404 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $481,705.
As of the Q4 2025 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 61,417 shares, as reported at the end of Q2 2024.